A Protective Role for Complement C3 Protein during Pandemic 2009 H1N1 and H5N1 Influenza A Virus Infection

• Kevin B. O'Brien,

  Affiliations Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, United States of America, Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Thomas E. Morrison,

  Affiliation Department of Microbiology, University of Colorado–Denver, Aurora, Colorado, United States of America

  ⨯
• David Y. Dundore,

  Affiliation Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯
• Mark T. Heise,

  Affiliations Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, United States of America, Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States of America, Carolina Vaccine Institute, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Stacey Schultz-Cherry

  * E-mail: stacey.schultz-cherry@stjude.org

  Affiliation Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯